Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-20

Clinical Trial Update: Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind trial comparing diclofenac to placebo in patients with post-ERCP pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac (diclofenac)

Snippet

Sponsor: Specialized Arab Hospital | Conditions: Post-ERCP Acute Pancreatitis. | Phase 1 | Status: COMPLETED